Laurence A Fitzgerald

Title: Laurence A Fitzgerald: Innovator in Peptide Technology

Introduction

Laurence A Fitzgerald is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of peptide technology, particularly through his innovative work on oligopeptides derived from the GPIIIa protein. His research has implications for medical applications, especially in the context of aggregation mediators.

Latest Patents

Fitzgerald holds a patent for "Peptides derived from GPIIIa." This invention provides oligopeptides that correspond to specific regions of the GPIIIa protein, which are capable of binding aggregation mediators such as fibrinogen. The oligopeptides typically comprise between 5 to 20 amino acids, making them non-immunogenic and easy to produce, formulate, and administer. This patent highlights his innovative approach to addressing complex biological interactions.

Career Highlights

Fitzgerald has been associated with Cor Therapeutics, Inc., where he has furthered his research and development efforts. His work at the company has allowed him to explore the practical applications of his inventions in the pharmaceutical industry. His contributions have been instrumental in advancing the understanding of peptide interactions in medical science.

Collaborations

Fitzgerald has collaborated with esteemed colleagues such as David R Phillips and Israel F Charo. These partnerships have enriched his research endeavors and have fostered a collaborative environment for innovation in peptide technology.

Conclusion

Laurence A Fitzgerald's work in peptide technology exemplifies the impact of innovative thinking in the medical field. His patent on GPIIIa-derived oligopeptides showcases his commitment to advancing scientific knowledge and improving therapeutic options.